ARCHIVES

In Brief: DeVita On Laetrile Hit List; Hammer Removal As Panel Head Sought By Love Canal Activist

This article is from The Cancer Letter archive.

Vol. 07 No. 45 | November 6, 1981

Download PDF Visit The Full Archive

Related Articles

R01 and P01 Grants Will No Longer Support Phase III Clinical Trials

July 25, 2013

Appropriations: Senate Committee Approves 4.5 Percent Cut To Defense Dept. Cancer Research Funding

July 25, 2014

In the States: Michigan to Allocate $50 Million Annually To Life Sciences

July 23, 1999

Committee Drafts QRA Definition

November 19, 1982

Case Study: The Post-Surgical Treatment Of A Child With Medulloblastoma At The Burzynski Clinic

September 25, 1998

Science Policcy: HHS Concludes NIH May und Human Stem Cell REsearch

January 22, 1999